ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Bhatt
Deepak L
DL
Scheiman
James
J
Abraham
Neena S
NS
Antman
Elliott M
EM
Chan
Francis K L
FK
Furberg
Curt D
CD
Johnson
David A
DA
Mahaffey
Kenneth W
KW
Quigley
Eamonn M
EM
Harrington
Robert A
RA
Bates
Eric R
ER
Bridges
Charles R
CR
Eisenberg
Mark J
MJ
Ferrari
Victor A
VA
Hlatky
Mark A
MA
Kaul
Sanjay
S
Lindner
Jonathan R
JR
Moliterno
David J
DJ
Mukherjee
Debabrata
D
Schofield
Richard S
RS
Rosenson
Robert S
RS
Stein
James H
JH
Weitz
Howard H
HH
Wesley
Deborah J
DJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D000077144:Clopidogrel; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control*; D016481:Helicobacter Infections / Q000175:diagnosis / Q000517:prevention & control*; D016480:Helicobacter pylori; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D012955:Societies, Medical; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin